CEACAM5 and non-small cell lung carcinoma: In conclusion, the results of this retrospective follow‐up study support the determination of both CEA and LDH serum levels for identifying subgroups of platinum‐based chemotherapy treated NSCLC patients differing in radiological response and overall survival.